A Comparative Study on Asanadi Yoga with Shalvarga and Metformin on Sthula Madhumeha with special reference to Type 2 Diabetes Mellitus specifically on HbA1c and Lipid Profile

Shweta Ramesh Aswar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Patient having fasting plasma glucose level 126mg/dl to 200mg/dl and post prandial plasma glucose level 200mg/dl to250mg/dl.
•2.HbA1c is 6.5% up to 8.5%. (In standardised assay, the HbA1c approximates the estimated average glucose value according to ADAG formula (A1c Derivated
•Average Glucose Level) that is 140mg/dl to197mg/dl[29]
•3.Patients fulfilling criteria of diagnosis and having clinical features of Sthula
•Madhumeha (Diabetes Mellitus)
•4.Patients having BMI more than 23Kg/m2 up to 30Kg/m2 will be selected.
•5.Those are willing to participate in trial and ready to give written consent.
•6.Patients with controlled Hypertension.

•1.Patients who already taken anti Diabetic drugs.
•2.Patients having Insulin Dependent Diabetes Mellitus and Juvenile Diabetes and various other types of Diabetes except Type II DM
•3.Patients having complications such as vasculopathy, nephropathy, retinopathy and neuropathy.
•4.Patients having other systemic complications like hepatic, renal and cardiac problems.
•5.Pregnant and lactating females not included in this study.
•6.Patients who are currently participating in any other clinical trials since last 6 months.

发起方

Shweta Ramesh Aswar